Neurodegeneration the RNA way - PubMed
Review
Neurodegeneration the RNA way
Abigail J Renoux et al. Prog Neurobiol. 2012 May.
Abstract
The expression, processing, transport and activities of both coding and non-coding RNAs play critical roles in normal neuronal function and differentiation. Over the past decade, these same pathways have come under scrutiny as potential contributors to neurodegenerative disease. Here we focus broadly on the roles of RNA and RNA processing in neurodegeneration. We first discuss a set of "RNAopathies", where non-coding repeat expansions drive pathogenesis through a surprisingly diverse set of mechanisms. We next explore an emerging class of "RNA binding proteinopathies" where redistribution and aggregation of the RNA binding proteins TDP-43 or FUS contribute to a potentially broad range of neurodegenerative disorders. Lastly, we delve into the potential contributions of alterations in both short and long non-coding RNAs to neurodegenerative illness.
Copyright © 2011 Elsevier Ltd. All rights reserved.
Figures
![Fig. 1](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89ff/3582174/62c1e9e7a5c3/nihms341626f1.gif)
Mechanisms underlying RNA mediated neurodegeneration in nucleotide repeat disorders. Bidirectional transcription atloci with expanded nucleotide repeats leads to the generation of multiple potentially toxic products. (A) Sense transcripts of tri-nucleotide CUG (shown here), CAG, or CGG repeats form secondary mRNA hairpin structures that can bind to and sequester RNA-binding proteins. (B and C) The decreased availability of RNA binding proteins such as splicing factors leads to alterations in the splicing and expression of other mRNAs in trans. Transcription factors and other nucleotide associated proteins may also be sequestered with effects on neuronal homeostasis. (D) Antisense transcription through the repeats leads to the generation of other potentially toxic mRNA sequences. These antisense transcripts sometimes contain open reading frames through the repeat, leading to translation of potentially toxic amino acid homopolymer production (e.g. polyglutamine containing proteins). (E) Homopolymer containing proteins may also be generated through a novel process known as repeat-associated non-ATG initiated (RAN) translation. Shown is the production of a polyglutamine peptide; however, alternative homopolymers in all three potential reading frames may be generated from each transcript.
![Fig. 2](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89ff/3582174/206fbac3c6fc/nihms341626f2.gif)
TDP-43 alterations in ALS and other neurodegenerative disorders. (A) TDP-43 is a nuclear protein which associates with the RNA polymerase Pol II on target DNA sequences, and participates in mRNA splicing. (B) Some TDP-43 is also exported from the nucleus associated with RNA-binding proteins on a subset of mRNAs. (C) Chronic neuronal stressors or mutations in TDP-43 lead to the translocation of the majority of TDP-43 to the cytoplasm. (D) This results in a loss of TDP-43s normal nuclear functions related to splicing and transcriptional regulation. (E) The increase in cytoplasmic TDP-43 results in a toxic gain-of-function via generation of TDP-43 protein aggregates as well as the accumulation of TDP-43 in cytoplasmic stress granules.
Similar articles
-
RNA-mediated toxicity in neurodegenerative disease.
Belzil VV, Gendron TF, Petrucelli L. Belzil VV, et al. Mol Cell Neurosci. 2013 Sep;56:406-19. doi: 10.1016/j.mcn.2012.12.006. Epub 2012 Dec 29. Mol Cell Neurosci. 2013. PMID: 23280309 Free PMC article. Review.
-
Neurodegeneration and RNA-binding proteins.
De Conti L, Baralle M, Buratti E. De Conti L, et al. Wiley Interdiscip Rev RNA. 2017 Mar;8(2). doi: 10.1002/wrna.1394. Epub 2016 Sep 22. Wiley Interdiscip Rev RNA. 2017. PMID: 27659427 Review.
-
The function of RNA-binding proteins at the synapse: implications for neurodegeneration.
Sephton CF, Yu G. Sephton CF, et al. Cell Mol Life Sci. 2015 Oct;72(19):3621-35. doi: 10.1007/s00018-015-1943-x. Epub 2015 Jun 6. Cell Mol Life Sci. 2015. PMID: 26047658 Free PMC article. Review.
-
RNA processing-associated molecular mechanisms of neurodegenerative diseases.
Tang AY. Tang AY. J Appl Genet. 2016 Aug;57(3):323-33. doi: 10.1007/s13353-015-0330-5. Epub 2015 Dec 3. J Appl Genet. 2016. PMID: 26634851 Review.
-
The Long Non-Coding RNAs in Neurodegenerative Diseases: Novel Mechanisms of Pathogenesis.
Riva P, Ratti A, Venturin M. Riva P, et al. Curr Alzheimer Res. 2016;13(11):1219-1231. doi: 10.2174/1567205013666160622112234. Curr Alzheimer Res. 2016. PMID: 27338628 Review.
Cited by
-
Toxic RNA as a driver of disease in a common form of ALS and dementia.
Orr HT. Orr HT. Proc Natl Acad Sci U S A. 2013 May 7;110(19):7533-4. doi: 10.1073/pnas.1305239110. Epub 2013 Apr 29. Proc Natl Acad Sci U S A. 2013. PMID: 23630297 Free PMC article. No abstract available.
-
Kinoshita C, Okamoto Y, Aoyama K, Nakaki T. Kinoshita C, et al. Clocks Sleep. 2020 Jul 23;2(3):282-307. doi: 10.3390/clockssleep2030022. eCollection 2020 Sep. Clocks Sleep. 2020. PMID: 33089205 Free PMC article. Review.
-
Koon AC, Chan HY. Koon AC, et al. Front Cell Neurosci. 2017 Mar 21;11:70. doi: 10.3389/fncel.2017.00070. eCollection 2017. Front Cell Neurosci. 2017. PMID: 28377694 Free PMC article. Review.
-
Gazy I, Miller CJ, Kim GY, Usdin K. Gazy I, et al. Front Cell Dev Biol. 2020 Jun 30;8:482. doi: 10.3389/fcell.2020.00482. eCollection 2020. Front Cell Dev Biol. 2020. PMID: 32695777 Free PMC article.
-
TDP-43 suppresses CGG repeat-induced neurotoxicity through interactions with HnRNP A2/B1.
He F, Krans A, Freibaum BD, Taylor JP, Todd PK. He F, et al. Hum Mol Genet. 2014 Oct 1;23(19):5036-51. doi: 10.1093/hmg/ddu216. Epub 2014 May 8. Hum Mol Genet. 2014. PMID: 24920338 Free PMC article.
References
-
- Arai T, Mackenzie IR, et al. Phosphorylated TDP-43 in Alzheimer's disease and dementia with Lewy bodies. Acta Neuropathol. 2009;117(2):125–136. - PubMed
-
- Arocena DG, Iwahashi CK, et al. Induction of inclusion formation and disruption of lamin A/C structure by premutation CGG-repeat RNA in human cultured neural cells. Hum Mol Genet. 2005;14(23):3661–3671. - PubMed
-
- Asikainen S, Rudgalvyte M, et al. Global microRNA expression profiling of Caenorhabditis elegans Parkinson's disease models. J Mol Neurosci. 2010;41(1):210–218. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous